-
Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC)
Tuesday, March 12, 2013 - 1:19pm | 820Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the final two weeks of February. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN), Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Onyx...
-
Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)
Thursday, February 28, 2013 - 4:13pm | 841Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of February. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Illumina (NASDAQ: ILMN) and Vertex Pharmaceuticals (NASDAQ: VRTX) grew somewhat between the January 31...
-
Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)
Tuesday, February 12, 2013 - 2:29pm | 829Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the latter two weeks of January. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Vertex Pharmaceuticals (NASDAQ: VRTX) and VIVUS...
-
Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)
Saturday, January 26, 2013 - 1:17pm | 836Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of January. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Onyx Pharmaceuticals (NASDAQ: ONXX) and Vertex...
-
Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)
Friday, December 28, 2012 - 12:10pm | 823Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of December. The number of shares sold short in Amgen (NASDAQ: AMGN), Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN) and Illumina (NASDAQ: ILMN) grew somewhat between the...
-
Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)
Wednesday, December 12, 2012 - 1:57pm | 828Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the final two weeks of November. Shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN), Illumina (NASDAQ: ILMN) and Regeneron Pharmaceuticals (NASDAQ: REGN) grew somewhat between the November 15 and...
-
Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)
Monday, November 12, 2012 - 2:24pm | 844Read More...The short interest in biotech and emerging pharmaceutical companies was mixed in the final two weeks of October. Shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Illumina (NASDAQ: ILMN) and VIVUS (NASDAQ: VVUS) grew somewhat between...
-
Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)
Thursday, October 25, 2012 - 2:09pm | 847Read More...The short interest in biotech and emerging pharmaceutical companies was mixed in the first two weeks of October. Shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN), Amgen (NASDAQ: AMGN), Celgene (NASDAQ: CELG), Dendreon (NASDAQ: DNDN), Illumina (NASDAQ: ILMN), Onyx Pharmaceuticals (NASDAQ...
-
Short Interest Swings in Biotech Stocks (BIIB, CELG, GILD)
Monday, October 15, 2012 - 6:59am | 826Read More...After largely rising in the previous period, short interest in biotech and emerging pharmaceutical companies was mixed in the final two weeks of September. Shares sold short in Amgen (NASDAQ: AMGN), Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Illumina (NASDAQ: ILMN), Onyx...
-
Short Interest in Biotech Firms Resumes (BIIB, GILD, ILMN, REGN)
Wednesday, September 26, 2012 - 1:22pm | 492Read More...The short interest data is out from the September 14 settlement date. By and large, short sellers have resumed their gambles on biotech firms compared to the August 31 settlement date. Short interest had waned for the most part in the two weeks before the end of August. Two notable exceptions to...
-
Short Sellers Shy Away from Biotech Firms
Thursday, September 13, 2012 - 1:34pm | 575Read More...The short interest data is out from the August 31 settlement date. By and large short sellers have retreated from gambles on biotech firms, compared to the August 15 settlement date. A few notable exceptions were Amgen (NASDAQ: AMGN), for which short interest was higher by 8.8 percent to 12.8...
-
Goldman Sachs Updates Illumina Estimates
Friday, June 24, 2011 - 7:37am | 64Read More...Goldman Sachs is updating its Illumina Inc. (NASDAQ: ILMN) estimates to reflect “our latest sequencing system placement assumptions for both HiSeq and MiSeq for 2011-2014.” “We now believe the mix will shift more towards MiSeq than HiSeq and as a result our 2011-2013 EPS estimates go to $1.55, $2....
-
Morgan Stanley Provides Color on Illumina, Overweight
Tuesday, May 31, 2011 - 9:10am | 161Read More...Morgan Stanley provided color on Illumina (NASDAQ: ILMN) after meeting the company's CEO Jay Flatley. In a research report published today, Morgan Stanley maintained its optimism about the company's long-term prospects. In the report, Morgan Stanley states, "Early MiSeq orders appear to be...
-
Goldman Sachs PT Changes For 5/31
Tuesday, May 31, 2011 - 7:59am | 145Read More...Goldman Sachs has changed the price targets on the following companies: Affymetrix (NASDAQ: AFFX) from $4.50 to $5, Sell Bank of New York Mellon (NYSE: BK) from $30 to $29, Neutral Baxter International (NYSE: BAX) from $69 to $72, Buy CME Group (NASDAQ: CME) from $345 to $325, Neutral...
-
Morgan Stanley Raises PT on Illumina To $84
Friday, May 13, 2011 - 8:24am | 26Read More...Morgan Stanley has raised the price target on Illumina (NASDAQ: ILMN) from $78 to $84 and maintains its Outperform rating.
